Cargando…

Electrophysiological Manifestations of Cardiac Amyloidosis: JACC: CardioOncology State-of-the-Art Review

Cardiac amyloidosis (CA) is an infiltrative cardiomyopathy caused by the extracellular deposition of amyloid fibrils in the myocardium. Although cardiac amyloidosis patients primarily present with heart failure symptoms, arrhythmias and conduction system disease are frequently encountered. Atrial fi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hartnett, Jack, Jaber, Wael, Maurer, Matthew, Sperry, Brett, Hanna, Mazen, Collier, Patrick, Patel, Divyang R., Wazni, Oussama M., Donnellan, Eoin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	State-of-the-Art Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8543134/ https://www.ncbi.nlm.nih.gov/pubmed/34729522 http://dx.doi.org/10.1016/j.jaccao.2021.07.010

Ejemplares similares

ATTR Amyloidosis: Current and Emerging Management Strategies: JACC: CardioOncology State-of-the-Art Review
por: Griffin, Jan M., et al.
Publicado: (2021)

Cardiac Tumors: JACC CardioOncology State-of-the-Art Review
por: Tyebally, Sara, et al.
Publicado: (2020)

AL Amyloidosis: Current Chemotherapy and Immune Therapy Treatment Strategies: JACC: CardioOncology State-of-the-Art Review
por: Bianchi, Giada, et al.
Publicado: (2021)

Considerations of Competing Risks Analysis in Cardio-Oncology Studies: JACC: CardioOncology State-of-the-Art Review
por: Li, Yimei, et al.
Publicado: (2022)

Genetics of Anthracycline Cardiomyopathy in Cancer Survivors: JACC: CardioOncology State-of-the-Art Review
por: Bhatia, Smita
Publicado: (2020)

Venous and Arterial Thromboembolism in Patients With Cancer: JACC: CardioOncology State-of-the-Art Review
por: Gervaso, Lorenzo, et al.
Publicado: (2021)

The Role of Cardioprotection in Cancer Therapy Cardiotoxicity: JACC: CardioOncology State-of-the-Art Review
por: Omland, Torbjørn, et al.
Publicado: (2022)

Cancer Immunotherapy Beyond Checkpoint Blockade: JACC: CardioOncology State-of-the-Art Review
por: Welty, Nathan E., et al.
Publicado: (2022)

Screening for Coronary Artery Disease in Cancer Survivors: JACC: CardioOncology State-of-the-Art Review
por: Velusamy, Ragani, et al.
Publicado: (2023)

Incorporating Exercise Training into Cardio-Oncology Care: Current Evidence and Opportunities: JACC: CardioOncology State-of-the-Art Review
por: Wilson, Rebekah L., et al.
Publicado: (2023)

Common Pathophysiology in Cancer, Atrial Fibrillation, Atherosclerosis, and Thrombosis: JACC: CardioOncology State-of-the-Art Review
por: Leiva, Orly, et al.
Publicado: (2021)

Cancer Treatment-Related Cardiovascular Toxicity in Gynecologic Malignancies: JACC: CardioOncology State-of-the-Art Review
por: Parashar, Susmita, et al.
Publicado: (2023)

Cardiovascular Toxicities of BTK Inhibitors in Chronic Lymphocytic Leukemia: JACC: CardioOncology State-of-the-Art Review
por: Quartermaine, Cooper, et al.
Publicado: (2023)

Magnetic Resonance Imaging to Detect Cardiovascular Effects of Cancer Therapy: JACC CardioOncology State-of-the-Art Review
por: Harries, Iwan, et al.
Publicado: (2020)

Mechanistic and Clinical Overview Cardiovascular Toxicity of BRAF and MEK Inhibitors: JACC: CardioOncology State-of-the-Art Review
por: Glen, Claire, et al.
Publicado: (2022)

Atherosclerosis With Immune Checkpoint Inhibitor Therapy: Evidence, Diagnosis, and Management: JACC: CardioOncology State-of-the-Art Review
por: Suero-Abreu, Giselle Alexandra, et al.
Publicado: (2022)

Cardiovascular Toxicity of Proteasome Inhibitors: Underlying Mechanisms and Management Strategies: JACC: CardioOncology State-of-the-Art Review
por: Georgiopoulos, Georgios, et al.
Publicado: (2023)

Cardiac Interventions in Patients With Active, Advanced Solid and Hematologic Malignancies: JACC: CardioOncology State-of-the-Art Review
por: Leong, Darryl P., et al.
Publicado: (2023)

Cardiac Disease in Childhood Cancer Survivors: Risk Prediction, Prevention, and Surveillance: JACC CardioOncology State-of-the-Art Review
por: Leerink, Jan M., et al.
Publicado: (2020)

Immune Checkpoint Inhibitor Therapy in Oncology: Current Uses and Future Directions: JACC: CardioOncology State-of-the-Art Review
por: Tan, Sean, et al.
Publicado: (2022)

JACC: CardioOncology: The Meaning of Family
por: Ky, Bonnie, et al.
Publicado: (2021)

Proceedings From the Global Cardio-Oncology Summit: The Top 10 Priorities to Actualize for CardioOncology
por: Lenihan, Daniel J., et al.
Publicado: (2019)

JACC: CardioOncology: Reflections on Tremendous Growth With Gratitude
por: Ky, Bonnie
Publicado: (2022)

Cardiac Computed Tomography in Cardio-Oncology: JACC: CardioOncology Primer
por: Lopez-Mattei, Juan C., et al.
Publicado: (2021)

Cardiac Resynchronization Therapy for Transthyretin Cardiac Amyloidosis
por: Donnellan, Eoin, et al.
Publicado: (2020)

Cardiotoxicity of T-Cell Antineoplastic Therapies: JACC: CardioOncology Primer
por: Ganatra, Sarju, et al.
Publicado: (2022)

JACC: CardioOncology 2022 Young Author Award Highlight
por: Ky, Bonnie
Publicado: (2023)

AL Amyloidosis for Cardiologists: Awareness, Diagnosis, and Future Prospects: JACC: CardioOncology State-of-the-Art Review
por: Wechalekar, Ashutosh D., et al.
Publicado: (2022)

JACC: CardioOncology: Serving and Advancing Our Cardiovascular and Oncology Communities
por: Ky, Bonnie
Publicado: (2020)

JACC: CardioOncology: Poised to Serve a Maturing, Collaborative Field
por: Ky, Bonnie
Publicado: (2019)

Reflections on Our Inaugural Year of JACC: CardioOncology, With Gratitude and Tireless Devotion
por: Ky, Bonnie
Publicado: (2020)

Cardiometabolic Comorbidities in Cancer Survivors: JACC: CardioOncology State-of-the-Art Review
por: Zullig, Leah L., et al.
Publicado: (2022)

Cardiovascular Disease in Myeloproliferative Neoplasms: JACC: CardioOncology State-of-the-Art Review
por: Leiva, Orly, et al.
Publicado: (2022)

Developing a Clinical Cardio-Oncology Program and the Building Blocks for Success: JACC: CardioOncology How To
por: Fradley, Michael G., et al.
Publicado: (2023)

The Evolving Immunotherapy Landscape and the Epidemiology, Diagnosis, and Management of Cardiotoxicity: JACC: CardioOncology Primer
por: Zhang, Lili, et al.
Publicado: (2021)

#JACCCardioOnc: Evolution of a Dedicated Social Media Strategy for JACC: CardioOncology
por: Brown, Sherry-Ann, et al.
Publicado: (2021)

Cardiovascular Disease Related to Immune Therapy: JACC: CardioOncology Special Focus Issue
por: Ky, Bonnie
Publicado: (2022)

Cardioprotection in Patients at High Risk of Anthracycline-Induced Cardiotoxicity: JACC: CardioOncology Primer
por: Henriksen, Peter A., et al.
Publicado: (2023)

Potential Applications for Targeted Gene Therapy to Protect Against Anthracycline Cardiotoxicity: JACC: CardioOncology Primer
por: Kok, Cindy Y., et al.
Publicado: (2021)

Excessive Trabeculation of the Left Ventricle: JACC: Cardiovascular Imaging Expert Panel Paper
por: Petersen, Steffen E., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_r5jl5g16qtrhqgt16q63d6kseo